An Open-label, Single Dose Study to Determine the Metabolism and Elimination of [14C]E2609 in Healthy Male Subjects
Clinical trial NCT01975636 · COMPLETED
Trial details
- NCT number
- NCT01975636
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2013-11-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.